文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

水凝胶直肠间隔物在前列腺立体定向放疗中置入质量指标评分的验证

Validation of a Quality Metric Score to Assess the Placement of Hydrogel Rectal Spacer in Patients Treated With Prostate Stereotactic Radiation Therapy.
PubMed 文献 · Adv Radiat Oncol · 2024-01-19

本研究纳入30例接受立体定向体部放疗的前列腺癌患者,每例经会阴置入10 mL聚乙二醇水凝胶间隔物,并在置入前后分别行CT扫描生成10MV无均整器模式立体定向体部放疗计划。通过测量前列腺与直肠间隙得出间隔物质量评分(SQS),结果显示置入前后SQS分组差异有统计学意义,且SQS与置入前后直肠剂量学相关。

要点

  • 每例置入10 mL聚乙二醇水凝胶间隔物,置入前后各行CT扫描并生成10MV无均整器模式立体定向体部放疗计划。
  • 前列腺与直肠间隙按<0.3、0.3至0.9、≥1 cm分别赋0、1、2分,总体SQS取各测量点最低分。
  • 置入前后按总体SQS分组差异有统计学意义,SQS与置入前后直肠剂量学相关。

核心结论

  • 置入前后间隔物质量评分(SQS)与置入前后直肠剂量学相关。

研究设计与样本

  • 30例前列腺癌患者作为SPORT临床试验的一部分接受立体定向体部放疗,每例经会阴置入10 mL聚乙二醇水凝胶间隔物。
  • 置入前后分别行CT扫描,并基于各自图像生成10MV无均整器模式立体定向体部放疗计划。
  • 在前列腺基底、尖部和中腺平行于解剖中线的前后方向上测量前列腺与直肠间隙(PRI),于前列腺与直肠之间3个横向位置取值。
  • PRI评分标准为间隙<0.3 cm赋0分、0.3至0.9 cm赋1分、≥1 cm赋2分,总体SQS取各PRI评分的最低值。
  • 采用Fisher精确检验比较置入前后PRI与SQS差异,采用配对样本Wilcoxon秩和检验和Student t检验比较直肠剂量差异。

主要发现

  • 按总体SQS分组时,置入前与置入后患者间差异有统计学意义。
  • PRI汇总评分在基底部置入前后未达统计学显著,而在前列腺中线和尖部置入后显著更高。
  • 按PRI和SQS分组时,部分直肠剂量体积指标差异有统计学意义。

关键数值与推荐

  • PRI评分:间隙<0.3 cm为0分,0.3至0.9 cm为1分,≥1 cm为2分。
  • 总体SQS为各PRI评分中的最低值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文提到对SQS评分指标的改进来源和局限性进行了讨论,摘要中未列出具体条目。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the quality of the interspace between the prostate and rectum and assess the effect on the dose to the rectum by measuring the spacer quality score (SQS) before and after implanting a hydrogel rectal spacer. METHODS AND MATERIALS: Thirty patients with prostate cancer were treated with stereotactic ablative body radiation therapy as part of the SPORT clinical trial. Each patient had a 10 mL polyethylene glycol hydrogel spacer inserted transperineally. Computed tomography scans were acquired before and after spacer insertion, 10MV flattening filter free (FFF) stereotactic ablative body radiation therapy (SABR) treatment plans were generated using each image set. To calculate the SQS, the prostate-rectal interspace (PRI) was measured in the anterior-posterior orientation, parallel to the anatomic midline at the prostate base, apex, and midgland on the prespacer and postspacer computed tomography. Measurements were taken in 3 transverse positions between the prostate and the rectum, and PRI scores of 0, 1, and 2 were assigned if the interspace between prostate and rectum was <0.3, 0.3 to 0.9, or ≥1 cm, respectively. The overall SQS was the lowest of the PRI scores. Differences between prespacer and postspacer PRIs and SQS were investigated by performing Fisher's exact test and differences between doses to the rectum were investigated by performing the paired samples Wilcoxon rank-sum test and Student t test. RESULTS: Statistically significant differences between prespacer versus postspacer patients were found when grouping patients according to their overall SQS. The PRI summary score did not reach statistical significance between prespacer and postspacer at the base but was significantly higher for the prostate midline and apex. Statistically significant differences in some rectum dose-volume metrics were found when grouping patients according to their PRIs and SQS. CONCLUSIONS: SQS before and after the spacer insertion was evaluated and was found to be correlated with pre- and postspacer rectal dosimetry. Sources of improvement of the SQS scoring metric and limitations are discussed.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Giacometti V, McLaughlin O, Comiskey P, et al. Validation of a Quality Metric Score to Assess the Placement of Hydrogel Rectal Spacer in Patients Treated With Prostate Stereotactic Radiation Therapy. Adv Radiat Oncol. 2024. PMID: 38304109. doi:10.1016/j.adro.2023.101396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。